Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.
Joint Clinical Trials Office
Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality: A Precision Imaging Trial
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 17, 2023
Expanded Access Program for belantamab mafodotin in Patients with Relapsed/Refractory Multiple Myeloma who are Refractory to a Proteasome Inhibitor, and an Immunomodulatory Agent, and an Anti-CD38 Antibody
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 19, 2023
A Phase 1/2, Open-label, Dose escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Oral TP 3654 in Patients with Intermediate or High-risk Primary or Secondary Myelofibrosis
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 21, 2023
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Magrolimab versus Placebo in Combination with Venetoclax and Azacitidine in Newly Diagnosed, Previously Untreated Patients with Acute Myeloid Leukemia Who
Study Status:
Open to Enrollment
Primary Investigator:
Date: August 3, 2023
A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas
Study Status:
Open to Enrollment
Primary Investigator:
Date: August 9, 2023
A Single Arm Phase II Study with Safety Run-in of Peptide Receptor Radionuclide Therapy (PRRT) in Combination with Immunotherapy for Patients with Merkel Cell Cancer (HCRN MCC20-443; iPRRT Study)
Study Status:
Open to Enrollment
Primary Investigator:
Date: August 16, 2023
In Vivo Evaluation of Lymph Nodes Using Quantitative Ultrasound
Study Status:
Open to Enrollment
Primary Investigator:
Date: August 29, 2023
A Phase 1/2, Open Label, Dose Escalation and Expansion Study of TAC-001 in Patients with Select Advanced or Metastatic Solid Tumors
Study Status:
Open to Enrollment
Primary Investigator:
Date: September 1, 2023
A Phase 1, Open-Label, Multicenter Study of INCB123667 as Monotherapy in Participants With Selected Advanced Solid Tumors
Study Status:
Open to Enrollment
Primary Investigator:
Date: September 13, 2023
Preserving Erectile Function by Quantifying the Nerve-Sparing Step of the Robotic Prostatectomy
Study Status:
Open to Enrollment
Primary Investigator:
Date: September 13, 2023